[Skip to Content]
[Skip to Content Landing]
Viewpoint
June 4, 2014

Is Big Data the New Frontier for Academic-Industry Collaboration?

Author Affiliations
  • 1Merck and Company, Boston, Massachusetts
  • 2Harvard Medical School, Boston, Massachusetts
  • 3Boston Veterans Affairs Medical Center, Boston, Massachusetts
  • 4Regenstrief Institute, Indiana University School of Medicine, Indianapolis
JAMA. 2014;311(21):2171-2172. doi:10.1001/jama.2014.1845

Academic-industry research collaborations have long been a source of controversy in medicine. Advocates suggest that collaborations can focus academic researchers on important clinical and translational research problems and provide them with financial and capability-enhancing technical resources.1 Critics maintain that industry engagement distracts from, or distorts, the teaching and research missions of academia.2 Although regulatory and compliance frameworks have been established to govern these relationships, controversy continues to surround efforts to enhance industry and academia collaborations.

First Page Preview View Large
First page PDF preview
First page PDF preview
×